Back to top

Can The Uptrend Continue for Corcept Therapeutics (CORT)?
August 09, 2017

Read MoreHide Full Article

Investors certainly have to be happy with Corcept Therapeutics Incorporated (CORT - Free Report) and its short term performance. After all, the stock has jumped by 25.5% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for CORT?

While we can never know for sure, it is pretty encouraging that estimates for CORT have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: Tech Opportunity Worth $386 Billion in 2017                

From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.                                                                                                                                                                                                                                                                                                                                                                                                                                              

Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity.  Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Corcept Therapeutics Incorporated (CORT) - free report >>


More from Zacks Tale of the Tape

You May Like